海正药业：法维拉韦片作为公司的重要战略产品，公司已围绕可及性、知晓率方面整合内外部资源全力推进

互动易2025-05-30

有投资者向海正药业提问，建议海正全力推广法维拉韦早期抗病毒，目前我在的县级市医院和药店都没这个药。2025年1月，国家卫健委发布的《流行性感冒诊疗方案》将法维拉韦纳入推荐用药。法维拉韦还受到了全球范围的认可，俄罗斯、印度、土耳其、日本、阿联酋、沙特、泰国等COVID-19药物治疗指南及日本感染学会《COVID-19药物治疗对策第6版》推荐该药用于治疗轻至中度新型冠状病毒感染(COVID-19)。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2539246444?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-05-30 15:33","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2539246444","market":"sh","top_or_hot":-1,"title":"海正药业：法维拉韦片作为公司的重要战略产品，公司已围绕可及性、知晓率方面整合内外部资源全力推进","media":"互动易","content":"<div>\n<p>有投资者向海正药业提问， 建议海正全力推广法维拉韦早期抗病毒，目前我在的县级市医院和药店都没这个药。2025年1月，国家卫健委发布的《流行性感冒诊疗方案》将法维拉韦纳入推荐用药。法维拉韦还受到了全球范围的认可，俄罗斯、印度、土耳其、日本、阿联酋、沙特、泰国等COVID-19药物治疗指南及日本感染学会《COVID-19药物治疗对策第6版》推荐该药用于治疗轻至中度新型冠状病毒感染(COVID-19)。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530155410a6f2f466&s=b\">Source Link</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海正药业：法维拉韦片作为公司的重要战略产品，公司已围绕可及性、知晓率方面整合内外部资源全力推进</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海正药业：法维拉韦片作为公司的重要战略产品，公司已围绕可及性、知晓率方面整合内外部资源全力推进\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-30 15:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530155410a6f2f466&s=b><strong>互动易</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>有投资者向海正药业提问， 建议海正全力推广法维拉韦早期抗病毒，目前我在的县级市医院和药店都没这个药。2025年1月，国家卫健委发布的《流行性感冒诊疗方案》将法维拉韦纳入推荐用药。法维拉韦还受到了全球范围的认可，俄罗斯、印度、土耳其、日本、阿联酋、沙特、泰国等COVID-19药物治疗指南及日本感染学会《COVID-19药物治疗对策第6版》推荐该药用于治疗轻至中度新型冠状病毒感染(COVID-19)。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530155410a6f2f466&s=b\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0060","symbol_name":"抗癌","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530155410a6f2f466&s=b","article_id":"2539246444","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530155410a6f2f466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2539246444","pubTimestamp":1748590386,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2025年1月，国家卫健委发布的《流行性感冒诊疗方案》将法维拉韦纳入推荐用药。海复康是高效的RNA聚合酶抑制剂抗病毒药物，其作为广谱抗流感药物已经列入医保药品。法维拉韦片作为公司的重要战略产品，公司已围绕可及性、知晓率方面整合内外部资源全力推进，线下销售如进院等工作也已经在全面推广，广大患者还可以通过电商聚道购买该产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600267":"海正药业","BK0060":"抗癌","BK0028":"国家队","BK0239":"医药制造","BK0188":"融资融券"},"translate_title":"Hisun Pharmaceutical: As an important strategic product of the company, Favilavir tablets have been fully promoted by integrating internal and external resources around accessibility and awareness","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600267":1},"content_text":"有投资者向海正药业提问， 建议海正全力推广法维拉韦早期抗病毒，目前我在的县级市医院和药店都没这个药。2025年1月，国家卫健委发布的《流行性感冒诊疗方案》将法维拉韦纳入推荐用药。法维拉韦还受到了全球范围的认可，俄罗斯、印度、土耳其、日本、阿联酋、沙特、泰国等COVID-19药物治疗指南及日本感染学会《COVID-19药物治疗对策第6版》推荐该药用于治疗轻至中度新型冠状病毒感染(COVID-19)。公司回答表示，尊敬的投资者您好，非常感谢您的建议！海复康是高效的RNA聚合酶抑制剂抗病毒药物，其作为广谱抗流感药物已经列入医保药品。法维拉韦片作为公司的重要战略产品，公司已围绕可及性、知晓率方面整合内外部资源全力推进，线下销售如进院等工作也已经在全面推广，广大患者还可以通过电商聚道购买该产品。感谢您的关注！","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2539246444","isCrawlerRequest":true}